5 Amino 1 MQ Capsules

Buy 5 Amino 1 MQ Capsules Online

5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular methylation and metabolic regulation. Research has focused heavily on its potential effects on adipocyte metabolism, NAD+ pathways, and body-fat regulation.

Product Information

5-Amino-1MQ, chemically known as 5-amino-1-methylquinolinium, has been investigated as a selective NNMT inhibitor. Preclinical studies have shown effects on intracellular NAD+, S-adenosylmethionine, lipid synthesis, and body composition in animal models. 5-Amino-1MQ is a small-molecule NNMT inhibitor, not a peptide. It is commonly grouped with peptide and metabolic research products because of its research focus on body composition and cellular metabolism.

How It Works

5-Amino-1MQ inhibits NNMT, reducing formation of 1-methylnicotinamide (1-MNA). This can alter intracellular NAD+ and methyl-donor metabolism and influence pathways involved in lipid storage and cellular energy balance.

POTENTIAL BENEFITS

1. NNMT Inhibition Research

5-Amino-1MQ is a widely used research tool for investigating the biological role of NNMT and how this enzyme influences cellular metabolism.

2. Metabolic Research

Preclinical studies have shown changes in NAD+ and methylation-related metabolites following NNMT inhibition, making 5-Amino-1MQ relevant to metabolic-pathway research.

3. Lipid-Metabolism Research

Cellular and animal studies have reported reductions in lipogenesis and adipose accumulation, supporting continued research into NNMT's role in lipid storage.

4. Body-Composition Research

Animal studies using 5-Amino-1MQ have reported reductions in body weight and white adipose tissue, although these findings have not established equivalent effects in humans.

Dosage

There is no established human therapeutic dosage for 5-Amino-1MQ. Preclinical research has used experimental concentrations and animal dosing; one mouse study used 20 mg/kg three times daily. This animal protocol should not be interpreted as a human dosage.

Side Effects

Human safety data remain limited. Because NNMT participates in NAD+, methylation, and metabolic pathways, prolonged systemic inhibition could potentially produce effects beyond body-composition pathways.

References

1. Neelakantan et al. — NNMT inhibitors and diet-induced obesity in mice. PMID: 29155147
2. Reduced calorie diet combined with NNMT inhibition in DIO mice. PMID: 35013352
3. NNMT in cardiovascular disease and metabolic regulation. PMID: 41008588

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.